Abstract：Objective To explore the factors influencing hospitalization expenses of malignant tumor patients, and to provide scientific basis for reducing the economic burden of malignant tumor patients.Methods A retrospective analysis approach was used for path analysis on the influencing factors of hospitalization expenses of patients with 5 kinds of malignant tumors in a tertiary hospital from January 1, 2021 to December 31, 2021.Results The surgery level was the main factor affecting the hospitalization expenses of patients with malignant tumor (direct effect 0.50 and indirect effect 0.21); length of hospital stay was in the second place by influence on hospitalization expenses of malignant tumor patients (direct effect 0.58), followed by malignant bronchus and lung tumors (direct effect 0.27, and indirect effect 0.30), malignant esophagus tumors (direct effect 0.17, and indirect effect 0.32), malignant stomach tumors (direct effect 0.21 and indirect effect 0.22), malignant breast tumors (direct effect 0.15 and indirect effect 0.28), whether first-class or special nursing or not (direct effect 0.04 and indirect effect 0.15), whether transferred between departments (indirect effect 0.15), whether critical or severe (direct effect 0.08), age(direct effect-0.08), drug proportion (direct effect -0.03 and indirect effect 0.10), whether with medical insurance (direct effect 0.03).Conclusion The main factors affecting the hospitalization expenses of malignant tumor patients are the surgery level and hospitalization days, so it is necessary to reduce the hospitalization expenses of patients with malignant tumors by shortening the average hospitalization days and strengthening perioperative management.
曹丙艳. 某三级甲等医院恶性肿瘤患者住院费用影响因素的通径分析[J]. 中国医院统计, 2023, 30(2): 144-147.
Cao Bingyan. Path analysis of influencers of hospitalization expenses for patients with malignant tumors in a tertiary hospital. journal1, 2023, 30(2): 144-147.
［2］CAI Y, XUE M, CHEN W, et al. Expenditure of hospital care on cancer in China, from 2011 to 2015［J］. Chin J Cancer Res, 2017, 29(3):253-262. DOI: 10.21147/j.issn.1000-9604.2017.03.11.
